Merck & Co. Inc. (MRK)
78.91
-0.27 (-0.34%)
At close: Apr 14, 2025, 1:45 PM
Merck & Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health segment Revenue | 1.49B | 1.48B | 1.51B | 14.26B | 1.46B | 1.49B | 1.23B | 1.37B | 1.47B | 1.48B | 1.26B | 1.42B | 1.47B | 1.42B | 1.17B | 1.22B | 1.1B | 1.21B | 1.12B | 1.12B | 1.12B | 1.02B | 1.04B | 1.02B | 1.09B | 8.92B | 9.29B | 9.16B | 8.76B | 8.19B | 8.9B | 9.44B | 8.7B | 8.1B | 9.03B | 8.93B | 8.56B | 8.27B | 9.37B | 9.13B | 9.09B | 8.45B |
| Animal Health segment Revenue Growth | +0.34% | -1.92% | -89.41% | +879.60% | -2.35% | +21.22% | -10.28% | -6.54% | -1.01% | +17.53% | -11.01% | -3.74% | +3.81% | +21.40% | -4.26% | +10.81% | -9.31% | +8.20% | 0.00% | -0.18% | +9.66% | -1.06% | +1.47% | -6.33% | -87.78% | -3.99% | +1.46% | +4.53% | +7.01% | -8.08% | -5.71% | +8.54% | +7.35% | -10.22% | +1.14% | +4.22% | +3.61% | -11.78% | +2.58% | +0.52% | +7.53% | n/a |
| Pharmaceutical segment Revenue | 14.94B | 14.41B | 14.01B | 1.4B | 13.46B | 12.72B | 12.18B | 12.96B | 12.76B | 14.11B | 10.6B | 11.5B | 9.98B | 10.68B | 11.37B | 11.32B | 9.68B | 10.65B | 10.53B | 11.1B | 10.46B | 9.66B | 9.83B | 9.66B | 9.28B | 1.06B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharmaceutical segment Revenue Growth | +3.71% | +2.87% | +900.43% | -89.60% | +5.79% | +4.45% | -6.05% | +1.62% | -9.58% | +33.05% | -7.77% | +15.19% | -6.51% | -6.09% | +0.42% | +16.95% | -9.16% | +1.16% | -5.07% | +6.07% | +8.25% | -1.70% | +1.78% | +4.05% | +771.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 | Dec 30, 2018 | Dec 30, 2017 | Dec 30, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 28.48B | 27.21B | 22.43B | 21.03B | 20.32B | 18.21B | 17.42B | 18.48B | 6.49B | 7.42B | 7.89B | 5.1B | 4.83B | 3.77B |
| United States Revenue Growth | +4.68% | +21.32% | +6.65% | +3.45% | +11.60% | +4.52% | -5.70% | +184.58% | -12.52% | -5.92% | +54.63% | +5.52% | +28.32% | n/a |
| Europe, Middle East And Africa Revenue | 13.25B | 14.49B | 13.34B | 13.6B | 12.71B | 12.21B | 11.48B | 10.95B | 2.82B | 3.15B | 3.2B | n/a | n/a | n/a |
| Europe, Middle East And Africa Revenue Growth | -8.55% | +8.64% | -1.90% | +7.03% | +4.04% | +6.40% | +4.79% | +287.99% | -10.41% | -1.62% | n/a | n/a | n/a | n/a |
| China Revenue | 6.8B | 5.19B | 4.38B | 3.62B | 3.58B | 3.21B | 4.34B | 3.92B | n/a | n/a | n/a | n/a | n/a | n/a |
| China Revenue Growth | +31.03% | +18.57% | +20.81% | +1.14% | +11.55% | -25.94% | +10.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue | 3.23B | 3.63B | 2.73B | 3.38B | 3.21B | 2.91B | 3.12B | 2.85B | n/a | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | -11.13% | +33.13% | -19.25% | +5.27% | +10.24% | -6.82% | +9.70% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue | 3.16B | 3.61B | 2.41B | 2.86B | 2.94B | 2.42B | 2.34B | 2.15B | n/a | n/a | n/a | n/a | n/a | n/a |
| Japan Revenue Growth | -12.45% | +50.15% | -15.96% | -2.68% | +21.86% | +3.25% | +8.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Latin America Revenue | 3.09B | 2.58B | 2.21B | 2.27B | 2.47B | 2.18B | 1.42B | 1.46B | n/a | n/a | n/a | n/a | n/a | n/a |
| Latin America Revenue Growth | +19.52% | +17.04% | -2.99% | -7.90% | +13.05% | +53.59% | -2.40% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenue | 2.1B | 2.57B | 1.22B | 1.23B | 1.61B | 1.15B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenue Growth | -18.07% | +110.32% | -0.65% | -23.47% | +39.77% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.3B | 2.73B | 2.74B | 2.48B | 2.8B | 2.52B | 2.7B | 2.48B | 2.69B | 2.52B | 2.51B | 2.32B | 2.83B | 2.34B | 2.28B | 2.19B | 3.08B | 2.06B | 2.08B | 2.56B | 2.89B | 2.59B | 2.71B | 2.42B | 2.64B | 2.44B | 2.51B | 2.51B | 2.58B | 2.46B | 2.5B | 2.47B | 2.59B | 2.39B | 2.46B | 2.32B | 2.62B | 2.47B | 2.62B | 2.6B |
| Selling, General, and Administrative Revenue Growth | +20.69% | -0.29% | +10.31% | -11.45% | +11.31% | -6.77% | +9.00% | -7.74% | +6.63% | +0.32% | +8.14% | -17.92% | +21.15% | +2.41% | +4.30% | -29.11% | +49.76% | -1.20% | -18.40% | -11.56% | +11.59% | -4.54% | +11.84% | -8.25% | +8.19% | -2.59% | 0.00% | -2.75% | +4.88% | -1.64% | +1.13% | -4.67% | +8.36% | -2.64% | +6.04% | -11.36% | +5.78% | -5.79% | +0.88% | n/a |
| Research and Development Revenue | 4.58B | 5.86B | 3.5B | 3.99B | 9.63B | 3.31B | 13.32B | 4.28B | 3.77B | 4.4B | 2.8B | 2.58B | 3.07B | 2.44B | 4.32B | 2.41B | 5.84B | 3.35B | 2.08B | 2.21B | 2.55B | 3.2B | 2.19B | 1.93B | 2.21B | 2.07B | 2.27B | 3.2B | 2.28B | 4.41B | 1.78B | 1.83B | 4.65B | 1.66B | 2.15B | 1.66B | 1.8B | 1.5B | 1.67B | 1.74B |
| Research and Development Revenue Growth | -21.80% | +67.49% | -12.32% | -58.53% | +191.11% | -75.17% | +211.53% | +13.27% | -14.19% | +57.22% | +8.62% | -16.04% | +25.48% | -43.42% | +79.15% | -58.68% | +74.29% | +60.62% | -5.61% | -13.30% | -20.47% | +46.37% | +13.36% | -12.78% | +7.06% | -9.06% | -28.85% | +40.11% | -48.31% | +147.64% | -2.62% | -60.64% | +179.39% | -22.64% | +29.66% | -7.73% | +19.87% | -10.18% | -3.86% | n/a |